To: DuckTapeSunroof who wrote (745823 ) 7/22/2006 1:59:18 PM From: PROLIFE Read Replies (3) | Respond to of 769669 of course the veto it does not stop research, lowlifes such as yourself ALWAYS find a way to make yourselves more important than others. Private money will always be available for research, I just don't want any more of my tax dollars being used to do it. Even a simpleton such as yourself can understand that, right?Disability Rights Advocate Backs Bush Embryonic Stem Cell Research Bill Veto Washington, DC (LifeNews.com) -- A disability rights advocate who has been a spinal cord injured quadriplegic for nearly four decades says she is happy President Bush vetoed a bill that would have forced taxpayers to fund embryonic stem cell research. Joni Eareckson Tada was among those gathered at the White House as the president announced why he vetoed the measure. Joining fellow disability advocates, ethicists, researchers, theologians and legislators, Tada said she stands with "countless Americans with disabilities who believe that our cause is not advanced when human life is sacrificed in hopes of finding a cure." "People like me -- who are medically fragile -- are left vulnerable and exposed in a society that views human life as a commodity which can be experimented upon or exploited," she explained. Tada said the disability community has another vested interest in the Presidential veto. Despite lack of reporting by the media, people with disabilities can be encouraged by recent and dramatic advancements in adult stem cell research, she said. Adult cells may be more elastic than scientists previously thought and are offering short-cuts to treatment which embryonic cells cannot match. Over 70 medical conditions are either being treated using adult stem cell therapies or are presently in clinical trials. “I am grateful for the principled stand our President has taken, first and foremost because of the sanctity of human life, but also because restrictions on use of taxpayer dollars may well encourage funding in the overlooked and less commercially viable field of adult stem cell therapy," Tada explained.lifenews.com